Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies. (Q37035264)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18088228%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18088228%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18088228%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Dimitrios H Roukos

series ordinal

1

1 reference

17 August 2017

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18088228%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18088228%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18088228%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18088228%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

29-39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18088228%20AND%20SRC:MED&resulttype=core&format=json

Perspectives in the treatment of gastric cancer.

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Novel targets in gastric and esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Genetic screening for signal transduction in the era of network biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Cancer genes and the pathways they control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

The consensus coding sequences of human breast and colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Reprogramming metastatic tumour cells with embryonic microenvironments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Patterns of somatic mutation in human cancer genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

The genomic landscapes of human breast and colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Molecular genetic tools shape a roadmap towards a more accurate prognostic prediction and personalized management of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Bias as a threat to the validity of cancer molecular-marker research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

The US Food and Drug Administration perspective on cancer biomarker development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Is molecular profiling ready for use in clinical decision making?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Timeline: Chemotherapy and the war on cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Drug insight: VEGF as a therapeutic target for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Lessons from phase III clinical trials on anti-VEGF therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Early-stage gastric cancer: a highly treatable disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Early onset gastric cancer: on the road to unraveling gastric carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

A review of the genomics of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Tumor metastasis: mechanistic insights and clinical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Mediators of vascular remodelling co-opted for sequential steps in lung metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

High-throughput genomic technology in research and clinical management of breast cancer. Exploiting the potential of gene expression profiling: is it ready for the clinic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

The prognostic role of a gene signature from tumorigenic breast-cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

A five-gene signature and clinical outcome in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

DNA microarrays in clinical oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Stem cells and their niches

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Calculated resistance in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Drinking from the fire hose--statistical issues in genomewide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

The role of companion diagnostics in the development and use of mutation-targeted cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Proteomic analysis of cancer tissues: shedding light on carcinogenesis and possible biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Metabolomics: available results, current research projects in breast cancer, and future applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Betting odds and genetic associations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

From signatures to models: understanding cancer using microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Synthetic lethal screen identification of chemosensitizer loci in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

Lung metastasis genes couple breast tumor size and metastatic spread.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

High-throughput oncogene mutation profiling in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.1.29

21 January 2018

Identifiers

DOI

10.1586/14737159.8.1.29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18088228%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference